Coherus Oncology (CHRS) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Coherus Oncology (CHRS) over the last 12 years, with Q3 2025 value amounting to 0.07.
- Coherus Oncology's Debt Ratio fell 2114.18% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year decrease of 2114.18%. This contributed to the annual value of 0.11 for FY2024, which is 7172.28% down from last year.
- Latest data reveals that Coherus Oncology reported Debt Ratio of 0.07 as of Q3 2025, which was down 2114.18% from 0.08 recorded in Q2 2025.
- Coherus Oncology's Debt Ratio's 5-year high stood at 0.61 during Q1 2023, with a 5-year trough of 0.07 in Q2 2024.
- Its 5-year average for Debt Ratio is 0.25, with a median of 0.11 in 2024.
- In the last 5 years, Coherus Oncology's Debt Ratio skyrocketed by 35927.85% in 2022 and then plummeted by 8706.38% in 2024.
- Quarter analysis of 5 years shows Coherus Oncology's Debt Ratio stood at 0.11 in 2021, then surged by 359.28% to 0.51 in 2022, then decreased by 22.29% to 0.4 in 2023, then crashed by 71.72% to 0.11 in 2024, then crashed by 36.22% to 0.07 in 2025.
- Its last three reported values are 0.07 in Q3 2025, 0.08 for Q2 2025, and 0.17 during Q1 2025.